Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA | Official Website
This is unchanged from the number of companies inspected in the previous month.
The companies inspected were involved in either the Food and Cosmetics, Biologics, Devices, or Drugs sectors.
There was one company in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct the organization's management operations. Additionally, one company had to take regulatory and/or administrative actions.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Result |
|---|---|---|---|
| Memorial Regional Hospital | Biologics | 03/18/2025 | No Action Indicated (NAI) |
| OMT, LLC | Devices | 03/05/2025 | Voluntary Action Indicated (VAI) |
| South Bear, Inc. | Food and Cosmetics | 03/07/2025 | Voluntary Action Indicated (VAI) |
| Sterling Distributors | Drugs | 03/06/2025 | Official Action Indicated (OAI) |
Alerts Sign-up